INS and metabolic disease: Indeed, the establishment of systemic inflammation, including high circulating levels of inflammatory cytokines (like TNF-a, IL-1B, 6, and 17), as well as an increased immune infiltrate in insulin-dependent tissues [50], without causing tissue damage, is the distinctive trait of metabolic disorders.